Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program, Cancer, vol.115, issue.7, pp.1531-1574, 2009. ,
Functions and mechanisms of action of CCN matricellular proteins, Int J Biochem Cell Biol, vol.41, issue.4, pp.771-83, 2009. ,
CCN1/CYR61: the very model of a modern matricellular protein, Cell Mol Life Sci, vol.68, pp.3149-63, 2011. ,
Identification of a novel integrin alphavbeta3 binding site in CCN1 (CYR61) critical for proangiogenic activities in vascular endothelial cells, J Biol Chem, vol.279, issue.42, pp.44166-76, 2004. ,
Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells, J Biol Chem, vol.277, issue.48, pp.46248-55, 2002. ,
CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth, Proc Natl Acad Sci, vol.95, issue.11, pp.6355-60, 1998. ,
The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives, Endocr Relat Cancer, vol.10, issue.2, pp.141-52, 2003. ,
Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer, Endocr Relat Cancer, vol.11, issue.4, pp.781-91, 2004. ,
Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells, Br J Cancer, vol.99, issue.10, pp.1656-67, 2008. ,
Cyr61 expression is associated with prognosis in patients with colorectal cancer, BMC Cancer, vol.14, p.164, 2014. ,
Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors, Oncogene, vol.34, issue.24, pp.3207-3220, 2015. ,
CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis, J Bone Miner Res, vol.26, issue.7, pp.1533-1575, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00626140
Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice, J Bone Miner Res, vol.27, issue.1, pp.58-67, 2012. ,
Complex networks orchestrate epithelialmesenchymal transitions, Nat Rev Mol Cell Biol, vol.7, issue.2, pp.131-173, 2006. ,
, Cell, vol.166, issue.1, pp.21-45, 2016.
Molecular mechanisms of epithelialmesenchymal transition, Nat Rev Mol Cell Biol, vol.15, issue.3, pp.178-96, 2014. ,
CDH11 expression is associated with survival in patients with osteosarcoma, Cancer Genomics Proteomics, vol.5, issue.1, pp.37-42, 2008. ,
TIM-3 expression in human osteosarcoma: correlation with the expression of epithelial-mesenchymal transition-specific biomarkers, Oncol Lett, vol.6, issue.2, pp.490-494, 2013. ,
Delocalized Claudin-1 promotes metastasis of human osteosarcoma cells, Biochem Biophys Res Commun, vol.466, issue.3, pp.356-61, 2015. ,
Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expression, Oncol Lett, vol.8, issue.1, pp.193-200, 2014. ,
Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis, Cancer Res, vol.70, issue.22, pp.9483-93, 2010. ,
Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis, J Bone Miner Res, vol.27, issue.10, pp.2108-2125, 2012. ,
Blockade of the RhoA-JNK-c-JunMMP2 cascade by atorvastatin reduces osteosarcoma cell invasion, J Biol Chem, vol.283, issue.45, pp.30549-56, 2008. ,
EMT-and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities, Mol Oncol, vol.11, issue.7, pp.860-77, 2017. ,
Cyr61/CCN1 signaling is critical for epithelialmesenchymal transition and stemness and promotes pancreatic carcinogenesis, Mol Cancer, vol.10, issue.8, 2011. ,
DOI : 10.1186/1476-4598-10-8
URL : https://molecular-cancer.biomedcentral.com/track/pdf/10.1186/1476-4598-10-8
Cyr61/ CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis, Asian Pac J Cancer Prev, vol.16, issue.7, pp.2659-64, 2015. ,
DOI : 10.7314/apjcp.2015.16.7.2659
URL : http://www.ndsl.kr/soc_img/society/apocp/POCPA9/2015/v16n7/POCPA9_2015_v16n7_2659.pdf
Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway, Clin Cancer Res, vol.11, issue.16, pp.5809-5829, 2005. ,
Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/ TWIST-1 signaling pathway, Mol Cancer, vol.13, p.236, 2014. ,
Cyr61 increases migration and MMP-13 expression via alphavbeta3 integrin, FAK, ERK and AP-1-dependent pathway in human chondrosarcoma cells, Carcinogenesis, vol.30, issue.2, pp.258-68, 2009. ,
DOI : 10.1093/carcin/bgn284
URL : https://academic.oup.com/carcin/article-pdf/30/2/258/17287138/bgn284.pdf
Cell surface receptors for CCN proteins, J Cell Commun Signal, vol.10, issue.2, pp.121-128, 2016. ,
DOI : 10.1007/s12079-016-0324-z
URL : http://europepmc.org/articles/pmc4882306?pdf=render
CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ ERK pathway, J Biol Chem, vol.285, issue.41, pp.31325-31361, 2010. ,
DOI : 10.1074/jbc.m109.087122
URL : http://www.jbc.org/content/285/41/31325.full.pdf
A connective tissue growth factor signaling receptor in corneal fibroblasts, Invest Ophthalmol Vis Sci, vol.53, issue.7, pp.3387-94, 2012. ,
The multi-functional role of insulin-like growth factor binding proteins in bone, Pediatr Nephrol, vol.20, issue.3, pp.261-269, 2005. ,
Regulation of insulin-like growth factors and IGF-binding proteins in bone tumours, Growth Regul, vol.6, issue.1, pp.10-15, 1996. ,
Prognostic value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis, Onco Targets Ther, vol.8, pp.1949-55, 2015. ,
Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma, J Surg Oncol, vol.105, issue.3, pp.235-278, 2012. ,
Van Den Berg CL. C-Jun N-terminal kinases mediate a wide range of targets in the metastatic Cascade, Genes Cancer, vol.4, issue.9, pp.378-87, 2013. ,
The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis, Nat Med, vol.10, issue.2, pp.182-188, 2004. ,
Therapy for osteosarcoma: where do we go from here?, Paediatr Drugs, vol.10, issue.5, pp.315-342, 2008. ,
DOI : 10.2165/00148581-200810050-00005
, BMC Cancer, vol.19, p.62, 2019.
Initial testing (stage 1) of the IGF-1 receptor inhibitor BMS-754807 by the pediatric preclinical testing program, Pediatr Blood Cancer, vol.56, issue.4, pp.595-603, 2011. ,
Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro, Clin Orthop Relat Res, vol.466, issue.9, pp.2168-75, 2008. ,
IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma, Cancer Lett, vol.336, issue.1, pp.222-252, 2013. ,
MicroRNA-133a inhibits osteosarcoma cells proliferation and invasion via targeting IGF-1R, Cell Physiol Biochem, vol.38, issue.2, pp.598-608, 2016. ,
A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma, Pediatr Blood Cancer, vol.63, issue.10, pp.1761-70, 2016. ,
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a sarcoma Alliance for research through collaboration study, Cancer, vol.120, issue.16, pp.2448-56, 2014. ,
Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors, Clin Cancer Res, vol.17, issue.3, pp.611-620, 2011. ,
Receptor tyrosine kinases in osteosarcoma: not just the usual suspects, Adv Exp Med Biol, vol.804, pp.47-66, 2014. ,
The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis, Int J Mol Sci, vol.17, issue.1, pp.138-52, 2016. ,
Prognostic value of the hippo pathway transcriptional coactivators YAP/TAZ and ?1-integrin in conventional osteosarcoma, Oncotarget, vol.7, issue.40, pp.64702-64712, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01482390
A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma, Cancer Lett, vol.407, pp.32-44, 2017. ,
Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin, Proc Natl Acad Sci, vol.108, issue.6, pp.2270-2275, 2011. ,
Osteosarcoma: accelerating Progress makes for a hopeful future, Front Oncol, vol.26, issue.8, p.4, 2018. ,
CYR61/CCN1 regulates Sclerostin levels and bone maintenance, J Bone Miner Res, vol.33, issue.6, pp.1076-89, 2018. ,
DOI : 10.1002/jbmr.3394
FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression, FASEB J, vol.22, issue.11, pp.3813-3835, 2008. ,
DOI : 10.1096/fj.08-106302
Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner, Clin Cancer Res, vol.15, issue.5, pp.1558-65, 2009. ,